CNS Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are histologic features of astrocytic tumors?

A

Grade 2: nuclear atypia only
Grade 3: nuclear atypia, focal or dispersed anaplasia, increased mitotic activity
Grade 4: microvascular proliferation, necrosis (and nuclear atypia, increased mitoses, but only the first two are pathognomonic for GBM).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

If a tumor is IDH wildtype, it is automatically GBM if one of the following is present:

A
  • TERT promoter mutation
  • EGFR amplification
  • combined gain of entire chromosome 7 and loss of entire chromosome 10 [+7/-10]
  • necrosis
  • microvascular proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are molecular biomarkers in CNS cancers

A

CDKN2A/B: homozygous deletion in IDH-mutant astrocytoma’s

GBM: automatically GBM if: TERT promoter mutation, EGFR amplification, +7/-10 copy number change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Glioma and GBM systemic therapies:

A

LGG: adjuvant PCV x 6
AO: PCV x 6
AA: RT -> Adjuvant TMZ 150mg/m2 d1-5 q28d cycles x 12 cycles
GBM: CRT with concurrent TMZ 75mg/m2 EVERY DAY -> adjuvant TMZ 150mg/m2 d1-5 q28d cycles x 6 cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Toxicity of WBRT/GBM treatment

A

ACUTE:
Alopecia (2nd to 3rd week)
Dermatitis
Fatigue
Transient worsening of symp d/t edema (esp 1st 2 wks)
N/V: esp brainstem
Otitis externa

LATE:
Alopecia (hair regrowth, if ever, 3-6m)
Telangectasias
RT necrosis
Diffuse leukoencephalopathy
Cerebral atrophy
Hearing loss
Retinopathy, cataract, visual change
Endocrine abnormality
Vasculopathy
Neurocog: decr new learning ability, short term memory, problem solving skills
2nd malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pituitary adenoma management
1) management
2) LC with RT
3) what labs to monitor for

A

GTR -> OBS
If medically inoperable or recurrence not amendable to sx: 50/25 (CTV 0mm duh)
LC: 90%

Most common deficiency after RT: GH: monitor with IGF-1.
Others: TSH, prolactin, cortisol, if a female with amenorrhea then LH and FSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bitemporal hemaniopsia caused by
If lesion in left occipital what visual field deficit?

A

1) chiasm
2): right homonymous hemianopsia (right visual field loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hormones produced by pituitary:
1) anterior (6)
2) posterior (2)

A

1) LSH, FSH, TSH, ACTH, GH, prolactin
2) Oxytocin, ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the indications for adjuvant radiation in pituitary adenomas/indications for post-op RT

A

Pituitary:
Non-functional: GTR-> observe. If SRT -> consider XRT on progression (this is benign, do not want 2% risk of 2ndary malignancy, this can be a GBM and the patient can die)

Functional:
XRT if unresectable, medically inoperable.
- IF functional, not controlled by medical management and recurrent after multiple surgeries then do XRT

DOSE: always say 54/30 or 50/25 do not say SRS for these hehe but if you need to know it, it is 15/1 non functional, 20/1 for functional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a potentially fatal complication of macroadenoma if untreated

A

Pituitary apoplexy: due to acute ischemic infarct or hemhorrahge of the pituitary: causes bitemporal hemaniopsia, double vision, and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Differential diagnosis for GBM (not including glioma)

A

Benign: Infection/abscess, AVM –arteriovenous malformation, Foreign body – ie: bullet, Hemorrhage/blood Multiple sclerosis (demyelinating plaque, Radiation necrosis
Malignant: Mets, Ependymoma, Germinoma, Schwannoma (acoustic neuroma), Pituitary adenoma, Primary CNS lymphoma, Meningioma, Choroid Plexus Tumors, Germ Cell Tumors

NOTE: DDX rim enhancing lesion: MAGIC DR:
M: etastasis
A: abscess
G: GBM
I: infarct
C: contusion

D: demyelinating (MS)
R: radiaiton necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is PCV and what class of chemotherapies

A

Procarbazine: (alkylating agent)
CCNU: (aka lomustine): alkylating agent
Vincristine: vinca alkyloid

TMZ:also alkylating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Question about dilantin:
1) side effects of dilantin:
2) what is the point of a loading dose

A

What are side effects of dilantin
1) N/V, abdominal pain, liver dysfunction, skin reaction, gingival hypertrophy
2) Achieve therapeutic level more quickly- need to monitor serum pheny level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TMZ class and S/E

A

Alkylating agent! Thrombocytopenia, fatigue, nausea!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how to stabilize seizure

A

Lorazepam 4mg IV over 2 minutes (for status epilepticus)
Load with phenytoin and refer to neurology for AED of choice
Start AED (levetiracetam, lamotrigine, topiramate)

17
Q

3 reasons to do MRI brain 24 hours post op

A
  • To assess for extent of resection (gross total vs subtotal with residual disease)/residual disease
  • To assess resolution of previous findings: midline shift, cerebral edema
  • To obtain imaging to prevent post-op changes from obscuring radiographic findings
18
Q

DDx posterior fossa mass (can say for both adult and peds)

A

BEAM:
brainstem glioma
Ependymoma
Astrocytoma: usually JPA
Medulloblastoma

ALSO: in adults: hemangioblastoma, lymphoma, mets
Benign: cyst, hematoma, abscess, infarct etc.

19
Q

When do give CSI
1) prophylactically (AKA always even when no visible disease)
2) for visible disease in spine

A

1) medulloblastoma, PNET
2) Ependymoma (if disseminated), pineal tumors, Germ cell tumors. Also for ALL prophylaxis

20
Q

Molecular features of oligo, astro

A

Both IDH mutated
- oligo: 1p19q co-deleted (almost always IDH1 mutated)
- Astro: CDKN2A/b: grade 4; ATRX, p53 mutant

21
Q

Meningoma genetic conditions

A

Tuberous sclerosis (give mTOR inhibitor), NF2 (also has bilateral schwannomas, spinal or intracranial meningomas, eye lesions, skin lesions), tuberous sclerosis

OTHER RFs: female, age, ionizing RT

22
Q
A
23
Q

Risk factors for Gliomas and genetic syndromes.

A

Prior CNS radiation, fam history, genetic syndromes (NF1 and NF2, TS, li fraumeni, turcot)